Cheongju, South Korea

Eun Hee Lee

This inventor holds 1 USPTO granted patent. Top assignee: Quantamatrix Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eun Hee Lee. Retrieved from https://idiyas.com/inventor/eun-hee-lee-x8c3qxhp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eun Hee Lee - Innovator in Bioactivity Testing Structures

Introduction

Eun Hee Lee is a notable inventor based in Cheongju-si, South Korea. She has made significant contributions to the field of bioactivity testing, particularly in the area of single cell tracking. Her innovative work has the potential to enhance diagnostic methods and drug susceptibility testing.

Latest Patents

Eun Hee Lee holds a patent for a "Bioactivity testing structure for single cell tracking using gelling agents." This invention relates to a novel bioactivity testing structure that facilitates rapid and simple drug susceptibility testing of bacteria. The structure allows for effective diagnosis and drug susceptibility testing of tuberculosis without the need to concentrate human sputum samples, ensuring accuracy and efficiency compared to conventional methods.

Career Highlights

Eun Hee Lee is associated with Quantamatrix Inc., where she continues to develop her innovative ideas. Her work focuses on improving diagnostic methods and drug screening processes, making significant strides in the medical field.

Collaborations

Eun Hee Lee collaborates with talented individuals such as Yong-Gyun Jung and Eun Guen Kim, contributing to a dynamic research environment that fosters innovation.

Conclusion

Eun Hee Lee's contributions to bioactivity testing structures represent a significant advancement in medical diagnostics. Her innovative approach promises to improve the speed and accuracy of drug susceptibility testing, making a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…